Pharmaceuticals

Latest Kaiser Health News Stories

Facebook Live: It’s 2018, Can Big Pharma Hold The Line Against Pricing Controls?

KHN Original

In this chat, KHN senior correspondent Jay Hancock discusses how drug-pricing battles could play out this year in D.C., state legislatures and beyond. What do we know about the drug industry’s agenda to quiet the drumbeat of cost control and transparency proposals? How will they officials target their efforts? Will the battles take place at the state level? Senior editor Stephanie Stapleton moderates.